Skip to main content

CV Sciences, Inc.

corporate_fare Company Profile

CV Sciences, Inc.

CVSI·OTC·Life Sciences·CIK 0001510964

CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The company sells its hemp extracts and other natural ingredients and products through both business-to-business (B2B) and business-to-consumer (B2C) channels. Its +PlusCBD™ branded products are sold at select retail locations across the U.S. and are the top-selling brands of hemp extracts in the natural products market, according to SPINS. +PlusCBD™ product benefits in healthy people are supported by human clinical research data and three published clinical case studies on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to achieve self-affirmed Generally Recognized as Safe (GRAS) status. On December 7, 2023, CV Sciences acquired Cultured Foods Sp. z.o.o., a leading European manufacturer and distributor of plant-based protein products, making it a wholly owned subsidiary. In January 2025, the company launched Lunar Fox™, a brand focused on distributing plant-based products in the U.S. market. The Cultured Foods™ and Lunar Fox™ brands offer a variety of 100% plant-based food products. In May 2024, CV Sciences acquired Elevated Softgels, LLC, a Colorado-based manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. In August 2024, the company engaged Maxim Group, LLC as a non-exclusive financial advisor and investment banker.

CV Sciences, Inc. (OTC:CVSI) is a publicly traded company in the Life Sciences sector. Wiseek monitors CVSI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Shareholders Reject Reverse Stock Split Proposal Amidst Going Concern Warning
  • Q1 Revenue Drops 11.4%, Net Loss Widens Amid Going Concern & Major Dilution
  • CV Sciences Q1 Revenue Plunges 11% to $3.2M Amid Regulatory Headwinds
  • CV Sciences Reports 11% Revenue Decline, Widened Net Loss in Q1 2026
  • CV Sciences Seeks Shareholder Approval for Reverse Stock Split Authorization to Facilitate Nasdaq Listing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$13.79M
Net Income
-$958K
Diluted EPS
-$0.01
Op. Cash Flow
-$407K
Free Cash Flow
-$516K
Gross Profit
$6.75M
Operating Income
-$470K
Cash & Equivalents
$278K
Total Debt
$1.65M
Debt / Equity
1.12×
Net Margin
-6.9%
Shares Outstanding
184.26M sh
Source: 10-K · filed 2026-03-26 · accession 0001193125-26-126598
Browse all tickers starting with C →
$0.024
52-week range · as of 2026-06-04 $0.0231 – $0.10
Market cap
$4.9M
Volume
1.1M (2.2× avg)
3-mo avg 512.9K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CVSI - Latest Insights

CVSI
Jun 04, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.02914
Real-time Price: $0.024 info
Change: -$0.00514 (-18%) info
Market Cap: $4.895M info
CVSI
May 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0301
Real-time Price: $0.024 info
Change: -$0.0061 (-20%) info
Market Cap: $4.895M info
CVSI
May 14, 2026, 4:08 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.03075
Real-time Price: $0.024 info
Change: -$0.00675 (-22%) info
Market Cap: $4.895M info
CVSI
May 14, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.03075
Real-time Price: $0.024 info
Change: -$0.00675 (-22%) info
Market Cap: $4.895M info
CVSI
Apr 14, 2026, 9:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.03073
Real-time Price: $0.024 info
Change: -$0.00673 (-22%) info
Market Cap: $4.895M info
CVSI
Apr 10, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.03609
Real-time Price: $0.024 info
Change: -$0.01209 (-33%) info
Market Cap: $4.895M info
CVSI
Mar 26, 2026, 5:14 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.033
Real-time Price: $0.024 info
Change: -$0.0090 (-27%) info
Market Cap: $4.895M info
CVSI
Mar 26, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.033
Real-time Price: $0.024 info
Change: -$0.0090 (-27%) info
Market Cap: $4.895M info
CVSI
Mar 10, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0456
Real-time Price: $0.024 info
Change: -$0.0216 (-47%) info
Market Cap: $4.895M info
CVSI
Mar 10, 2026, 5:00 PM EDT
Source: Acceswire
Importance Score:
8
Price at Filing: $0.0456
Real-time Price: $0.024 info
Change: -$0.0216 (-47%) info
Market Cap: $4.895M info